REG - Paccar Fin Europe - Publication Pricing Supplement Notes 30 PACCAR

PACCARAnnouncement

28/02/2020 10:05

RNS Number : 4805E
  
PACCAR Financial Europe B.V.
  
28 February 2020
  
 

Publication of Pricing Supplement
The following Pricing Supplement is available for viewing:
Pricing Supplement dated 28 February 2020 relating to the issue by PACCAR Financial Europe B.V. of €300,000,000 0.000 per cent. Notes due 3 March 2023 under the €2,500,000,000 Euro Medium Term Note Programme of PACCAR Financial Europe B.V., with the benefit of a Keep Well Agreement with PACCAR Inc.
To view the full document, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/4805E_1-2020-2-28.pdf
A copy of the Pricing Supplement has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/nsm.
For further information, please contact:
 
Timothy Claes 
PACCAR Financial Europe B.V.
Hugo van der Goeslaan 1 
5643 TW Eindhoven
The Netherlands 
Fax: +31 (0) 40 214 4310
DISCLAIMER - INTENDED ADDRESSEES
The Pricing Supplement must be read in conjunction with the listing particulars dated 4 July 2019 and the supplemental listing particulars dated 20 February 2020 (the "Listing Particulars"), which constitutes listing particulars given in compliance with the United Kingdom Listing Authority's listing rules under Part VI of the Financial Services and Markets Act 2000.
MiFID II professionals/ECPs-only / No PRIIPs KID - Manufacturer target market (MiFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA.
Please note that the information contained in the Listing Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Listing Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Listing Particulars is not addressed. Prior to relying on the information contained in the Listing Particulars, you must ascertain from the Listing Particulars whether or not you are part of the intended addressees of the information contained therein.
The Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the Notes may not be offered or sold directly or indirectly within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. Any forwarding, distribution or reproduction of the Listing Particulars in whole or in part is prohibited. Failure to comply with this notice may result in a violation of the Securities Act or the applicable laws of other jurisdictions. There will be no public offering of the Notes in the United States.
Your right to access this service is conditional upon complying with the above requirement. 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DOCSEFSUAESSESE